Novo Nordisk A/S (NYSE:NVO ... pharmaceutical company plans to build a new 1.4 million square foot manufacturing plant near Raleigh, North Carolina, doubling its size, the company said in a ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

As China embarks on its three-year "weight management" campaign, Novo Nordisk has stepped forward with its powerful tools to combat obesity. The company's commitment aligns with the national ...

STORY: Weight-loss drug Wegovy has driven Novo Holdings to fresh highs.The company said Wednesday (April 2) it nearly doubled ...

It subsequently sold three Catalent manufacturing plants to Novo Nordisk for $11 billion to boost Wegovy production. However, total assets under management dropped slightly to 142 billion euros in ...

The new plant will be one of the largest manufacturing investments in Novo Nordisk’s history and will add 1.4 million sq ft of production space for aseptic manufacturing and finished production ...

March 24 (Reuters) - Danish drugmaker Novo Nordisk ... China and US Inc, Trump's trade war feels much worse this time 4:01 AM UTC · Updated ago Asian Marketscategory China's manufacturing ...

United Biotechnology recently initiated a phase 2 trial for UBT251 in people with overweight or obesity in China. Earlier this month, Novo Nordisk announced headline results from the REDEFINE 2 ...

Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk , nearly doubled annual income and investment ...